TGTX earnings call for the period ending September 30, 2019.
News & Analysis: TG Therapeutics
The company has given back most of its 2019 gains, but does this change its previously bullish appraisal?
TGTX earnings call for the period ending June 30, 2019.
TGTX earnings call for the period ending March 31, 2019.
The stock price of this clinical-stage biotech has nearly doubled so far in 2019.
These three biotech stocks are worth buying this month.
A string of positive news on drugs in development sparked investor excitement.
Positive data from a cohort in a key trial ignited investor optimism.
A new year and reasons to remain hopeful for these three biotechs are around the corner.
Investors hit the exits last month after TG Therapeutics missed a key clinical milestone.